Search research articles
Contact Us
Filters
Showing results (111-120 of 157) with videos related to
Page
of 16
Sort By:
Molecular Pharmacology
|
March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors
C W Lin, K Shiosaki, T R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 1998
Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity
A A Hancock, M E Brune, D G Witte, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity
M W Holladay, H Kopecka, T R Miller, et al.
Journal of Medicinal Chemistry
|
January 21, 1994
Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus
R L Elliott, H Kopecka, M J Bennett, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 1993
Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs
Y K Shue, M D Tufano, G M Carrera, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2002
Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonists
David G Witte, Michael E Brune, Sweta P Katwala, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue
M J Bennett, A L Nikkel, B R Bianchi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series
M Cowart, M Sun, C Zhao, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists
R L Elliott, H Kopecka, M D Tufano, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo
M W Holladay, M J Bennett, M D Tufano, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 157) with videos related to
Sort By:
Page
of 16
Molecular Pharmacology
|
March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors
C W Lin, K Shiosaki, T R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 1998
Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity
A A Hancock, M E Brune, D G Witte, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity
M W Holladay, H Kopecka, T R Miller, et al.
Journal of Medicinal Chemistry
|
January 21, 1994
Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus
R L Elliott, H Kopecka, M J Bennett, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 1993
Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs
Y K Shue, M D Tufano, G M Carrera, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2002
Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonists
David G Witte, Michael E Brune, Sweta P Katwala, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue
M J Bennett, A L Nikkel, B R Bianchi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
September 7, 2007
A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series
M Cowart, M Sun, C Zhao, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists
R L Elliott, H Kopecka, M D Tufano, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo
M W Holladay, M J Bennett, M D Tufano, et al.
Page
of 16